Application note: Fast track antibody discovery
Posted: 7 March 2019 | Sphere Fluidics Ltd. | No comments yet
Learn more about an emerging high-throughput method for identifying and isolating rare cells secreting antigen-specific antibodies.
Antibody-derived biologics have become a major class of modern medicine, particularly in the fight against cancer and autoimmune diseases. Highly efficacious immunoglobulin-based drugs have been developed naturally via the antibody-producing B cells of the mammalian immune system, although finding rare cells with the right characteristics has always been challenging.
Please complete the form below in order to download this application note:
Related content from this organisation
- Application note: Fast-track antibody discovery: a high-throughput method for identifying and isolating rare secreting cells
- Application note: Streamlined genome engineering in picodroplets
- Which CHO cell is the right CHO cell?
- Expert view: How automation can improve cell stability and productivity in cell line development
- Case Study: Optimising upstream bioprocessing in cell line development
Related topics
Assays, Drug Discovery, Screening
Related organisations
Sphere Fluidics Ltd.
